(Q50554702)

15 March 2018

title

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients. (English)

1 reference

15 March 2018

1 reference

1 reference

3

1 reference

15 March 2018

author name string

Samir K Gupta

series ordinal

1

1 reference

15 March 2018

Bhavna Kantesaria

series ordinal

2

1 reference

15 March 2018

publication date

27 October 2011

1 reference

15 March 2018

European Journal of Clinical Pharmacology

published in

1 reference

15 March 2018

volume

68

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

415-418

1 reference

15 March 2018

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Ribavirin in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Hemodialysis clearance of intravenously administered ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1137-X

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22037562

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The clinical pharmacology of ribavirin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22037562

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00228-011-1137-X

1 reference

15 March 2018

1 reference

15 March 2018